Drug Trial Radar · NCT07594119
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
312
Planned (sponsor's estimate)
Start
Sep 1, 2026
Primary completion
Jul 2029
Study completion Sep 2029
Sponsor
- Lead sponsor
- Rapport Therapeutics Inc.Industry
- Sponsor type
- Industry
- First posted
- May 18, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a clinical research study for an investigational drug called RAP-219 in adult participants with focal seizures. This study is being conducted to determine if RAP-219 is safe and effective in reducing focal seizure frequency.
Conditions
- Focal Seizure
- Epilepsy
- Focal Epilepsy
Interventions
RAP-219Drug
RAP-219 medium dose tablets administered orally daily
RAP-219Drug
RAP-219 low dose tablets administered orally daily
PlaceboOther
Matching placebo tablets administered orally
Primary outcomes
What the sponsor says the trial is designed to measure.
- Median Percent Change in Seizure FrequencyTime frame: End of double-blind treatment period (end of week 14) vs Baseline
Locations
14 sites in 3 countries. Site status is shown where the registry gives one.
Clinical Study Center
Huntsville, Alabama · Recruiting
Clinical Study Center
Bentonville, Arkansas · Recruiting
Clinical Study Center
Colorado Springs, Colorado · Recruiting
Clinical Study Center
Maitland, Florida · Recruiting
Clinical Study Center
Miami, Florida · Recruiting
Clinical Study Center
Honolulu, Hawaii · Recruiting
Clinical Study Center
Chicago, Illinois · Recruiting
Clinical Study Center
Omaha, Nebraska · Recruiting
Clinical Study Center
New York, New York · Recruiting
Clinical Study Center
Raleigh, North Carolina · Recruiting
Clinical Study Center
Nashville, Tennessee · Recruiting
Clinical Study Center
Houston, Texas · Recruiting
Clinical Study Center
Melbourne, Australia · Recruiting
Clinical Study Center
Seoul, South Korea · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.